Mild to moderate psoriasis is managed with topical pharmacological therapies. This page summarises the clinical situation and gives a brief, partial sense of the approach — the complete structured protocol is available via the link below.
This is a first-line protocol for patients with mild to moderate psoriasis who are candidates for topical treatment. No prior treatment failure is required; this represents the initial pharmacological management step for this severity range.
The protocol outlines the use of specific topical agents for mild to moderate psoriasis — including coal tar preparations as one recommended option. Further agent selection, application guidance, and treatment course details are specified in the full protocol and are not shown here.
DOI: 10.1016/j.jaad.2020.07.087